Author
Listed:
- Indre Piragyte
(Max Planck Institute of Immunobiology and Epigenetics
University of Freiburg)
- Thomas Clapes
(Max Planck Institute of Immunobiology and Epigenetics)
- Aikaterini Polyzou
(Max Planck Institute of Immunobiology and Epigenetics
University of Freiburg)
- Ramon I. Klein Geltink
(Max Planck Institute of Immunobiology and Epigenetics)
- Stylianos Lefkopoulos
(Max Planck Institute of Immunobiology and Epigenetics
University of Freiburg)
- Na Yin
(Max Planck Institute of Immunobiology and Epigenetics)
- Pierre Cauchy
(Max Planck Institute of Immunobiology and Epigenetics)
- Jonathan D. Curtis
(Max Planck Institute of Immunobiology and Epigenetics)
- Lhéanna Klaeylé
(Max Planck Institute of Immunobiology and Epigenetics)
- Xavier Langa
(University of Bern)
- Cora C. A. Beckmann
(University of Freiburg)
- Marcin W. Wlodarski
(University of Freiburg)
- Patrick Müller
(Friedrich Miescher Laboratory of the Max Planck Society)
- Dominic Van Essen
(Institute for Research on Cancer and Aging Nice)
- Angelika Rambold
(Max Planck Institute of Immunobiology and Epigenetics
Freiburg University Medical Center)
- Friedrich G. Kapp
(University of Freiburg)
- Marina Mione
(University of Trento)
- Joerg M. Buescher
(Max Planck Institute of Immunobiology and Epigenetics)
- Erika L. Pearce
(Max Planck Institute of Immunobiology and Epigenetics)
- Alexander Polyzos
(Biomedical Research Foundation of the Academy of Athens)
- Eirini Trompouki
(Max Planck Institute of Immunobiology and Epigenetics)
Abstract
The H2.0-like homeobox transcription factor (HLX) regulates hematopoietic differentiation and is overexpressed in Acute Myeloid Leukemia (AML), but the mechanisms underlying these functions remain unclear. We demonstrate here that HLX overexpression leads to a myeloid differentiation block both in zebrafish and human hematopoietic stem and progenitor cells (HSPCs). We show that HLX overexpression leads to downregulation of genes encoding electron transport chain (ETC) components and upregulation of PPARδ gene expression in zebrafish and human HSPCs. HLX overexpression also results in AMPK activation. Pharmacological modulation of PPARδ signaling relieves the HLX-induced myeloid differentiation block and rescues HSPC loss upon HLX knockdown but it has no effect on AML cell lines. In contrast, AMPK inhibition results in reduced viability of AML cell lines, but minimally affects myeloid progenitors. This newly described role of HLX in regulating the metabolic state of hematopoietic cells may have important therapeutic implications.
Suggested Citation
Indre Piragyte & Thomas Clapes & Aikaterini Polyzou & Ramon I. Klein Geltink & Stylianos Lefkopoulos & Na Yin & Pierre Cauchy & Jonathan D. Curtis & Lhéanna Klaeylé & Xavier Langa & Cora C. A. Beckman, 2018.
"A metabolic interplay coordinated by HLX regulates myeloid differentiation and AML through partly overlapping pathways,"
Nature Communications, Nature, vol. 9(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-05311-4
DOI: 10.1038/s41467-018-05311-4
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Ram Bhupal Reddy & Samanta S Khora & Amritha Suresh, 2019.
"Molecular prognosticators in clinically and pathologically distinct cohorts of head and neck squamous cell carcinoma—A meta-analysis approach,"
PLOS ONE, Public Library of Science, vol. 14(7), pages 1-29, July.
- Nikolai Schleussner & Pierre Cauchy & Vedran Franke & Maciej Giefing & Oriol Fornes & Naveen Vankadari & Salam A. Assi & Mariantonia Costanza & Marc A. Weniger & Altuna Akalin & Ioannis Anagnostopoulo, 2023.
"Transcriptional reprogramming by mutated IRF4 in lymphoma,"
Nature Communications, Nature, vol. 14(1), pages 1-18, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-05311-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.